Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Challenges in the management of osteoporosis and vitamin D deficiency in HIV infection.

Brown TT.

Top Antivir Med. 2013 Jul-Aug;21(3):115-8. Review.

PMID:
23981599
[PubMed - indexed for MEDLINE]
Free Article
2.

Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.

McComsey GA, Kendall MA, Tebas P, Swindells S, Hogg E, Alston-Smith B, Suckow C, Gopalakrishnan G, Benson C, Wohl DA.

AIDS. 2007 Nov 30;21(18):2473-82.

PMID:
18025884
[PubMed - indexed for MEDLINE]
3.

Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.

PMID:
23074491
[PubMed]
Free PMC Article
4.

Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.

Levis S, Theodore G.

J Manag Care Pharm. 2012 May;18(4 Suppl B):S1-15; discussion S13.

PMID:
22716221
[PubMed - indexed for MEDLINE]
Free Article
5.

Bone health and human immunodeficiency virus infection.

Schafer JJ, Manlangit K, Squires KE.

Pharmacotherapy. 2013 Jun;33(6):665-82. doi: 10.1002/phar.1257. Epub 2013 Apr 1. Review.

PMID:
23553497
[PubMed - indexed for MEDLINE]
6.

Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies.

Walker Harris V, Brown TT.

J Infect Dis. 2012 Jun;205 Suppl 3:S391-8. doi: 10.1093/infdis/jis199. Review.

PMID:
22577213
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients.

Geller JL, Hu B, Reed S, Mirocha J, Adams JS.

Endocr Pract. 2008 Apr;14(3):293-7.

PMID:
18463035
[PubMed - indexed for MEDLINE]
8.

Fracture risks for women in long-term care: high prevalence of calcaneal osteoporosis and hypovitaminosis D.

Elliott ME, Binkley NC, Carnes M, Zimmerman DR, Petersen K, Knapp K, Behlke JM, Ahmann N, Kieser MA.

Pharmacotherapy. 2003 Jun;23(6):702-10.

PMID:
12820811
[PubMed - indexed for MEDLINE]
9.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

PMID:
18088161
[PubMed - indexed for MEDLINE]
Free Article
10.

Interventions for the treatment of decreased bone mineral density associated with HIV infection.

Lin D, Rieder MJ.

Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005645. Review.

PMID:
17443607
[PubMed - indexed for MEDLINE]
11.

Influence of vitamin D levels on bone mineral density and osteoporosis.

Sadat-Ali M, Al Elq AH, Al-Turki HA, Al-Mulhim FA, Al-Ali AK.

Ann Saudi Med. 2011 Nov-Dec;31(6):602-8. doi: 10.4103/0256-4947.87097.

PMID:
22048506
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Prevalence and risk factors for osteopenia/osteoporosis in an HIV-infected male population.

Tomazic J, Ul K, Volcansek G, Gorensek S, Pfeifer M, Karner P, Prezelj J, Vidmar G, Vidmar L.

Wien Klin Wochenschr. 2007;119(21-22):639-46.

PMID:
18043884
[PubMed - indexed for MEDLINE]
13.

Osteoporosis screening and risk management.

Wilkins CH.

Clin Interv Aging. 2007;2(3):389-94.

PMID:
18044189
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Clinical challenges in the management of osteoporosis.

Vondracek SF, Minne P, McDermott MT.

Clin Interv Aging. 2008;3(2):315-29. Review.

PMID:
18686753
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Anti-resorptive therapy for the prevention of postmenopausal osteoporosis : when should treatment begin?

Vestergaard P.

Treat Endocrinol. 2005;4(5):263-77. Review.

PMID:
16185096
[PubMed - indexed for MEDLINE]
16.

Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.

Barone A, Giusti A, Pioli G, Girasole G, Razzano M, Pizzonia M, Palummeri E, Bianchi G.

J Am Geriatr Soc. 2007 May;55(5):752-7.

PMID:
17493196
[PubMed - indexed for MEDLINE]
17.

Vitamin D deficiency and its association with low bone mineral density, HIV-related factors, hospitalization, and death in a predominantly black HIV-infected cohort.

Sherwood JE, Mesner OC, Weintrob AC, Hadigan CM, Wilkins KJ, Crum-Cianflone NF, Aronson NE.

Clin Infect Dis. 2012 Dec;55(12):1727-36. doi: 10.1093/cid/cis785. Epub 2012 Sep 12.

PMID:
22972869
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

[Prophylaxis and treatment of osteoporosis in patients with rheumatoid arthritis (ORA study)].

Heberlein I, Demary W, Bloching H, Braun J, Buttgereit F, Dreher R, Kuhn C, Lange U, Pollähne W, Zink A, Zeidler H, Häntzschel H, Raspe H.

Z Rheumatol. 2011 Nov;70(9):793-8, 800-2. doi: 10.1007/s00393-011-0872-9. German.

PMID:
21956827
[PubMed - indexed for MEDLINE]
19.

Vitamin D, bone, and HIV infection.

Yin M.

Top Antivir Med. 2012 Dec;20(5):168-72. Review.

PMID:
23363695
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Osteoporosis risk in premenopausal women.

Vondracek SF, Hansen LB, McDermott MT.

Pharmacotherapy. 2009 Mar;29(3):305-17. doi: 10.1592/phco.29.3.305. Review.

PMID:
19249949
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk